Technical Analysis for CATB - Catabasis Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 6.47 -3.14% -0.21
CATB closed down 1.18 percent on Wednesday, July 8, 2020, on 42 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical CATB trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -3.14%
20 DMA Resistance Bearish -4.29%
20 DMA Resistance Bearish -3.58%
Stochastic Reached Oversold Weakness -3.58%
Strong but Oversold Other -3.58%
Oversold Stochastic Weakness -3.58%
50 DMA Support Bullish 0.94%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.94%
NR7 Range Contraction 0.94%
Doji - Bullish? Reversal 0.94%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Catabasis Pharmaceuticals, Inc. (Catabasis) is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapeutics based on its safely metabolized and rationally targeted (SMART) linker technology platform. Its SMART linker technology platform is based on the concept of treating diseases by simultaneously modulating various biological targets in one or more related disease pathways. Catabasis engineers bi-functional product candidates that are conjugates of two molecules, or bioactives, each with known pharmacological activity, joined by one of its SMART linkers. Catabasis is also engaged in developing other product candidates for the treatment of lipid disorders. The Company's product development pipeline includes three clinical-stage product candidates, namely, CAT-1004, CAT-2000 series, including CAT-2054 and CAT-2003, and CAT-4001, and various programs in preclinical development.
Biopharmaceutical Diseases Lipid Disorders Cat

Is CATB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.75
52 Week Low 2.74
Average Volume 231,557
200-Day Moving Average 5.48
50-Day Moving Average 6.42
20-Day Moving Average 6.87
10-Day Moving Average 6.85
Average True Range 0.44
ADX 17.1
+DI 19.57
-DI 18.37
Chandelier Exit (Long, 3 ATRs ) 6.40
Chandelier Exit (Short, 3 ATRs ) 7.44
Upper Bollinger Band 7.55
Lower Bollinger Band 6.20
Percent B (%b) 0.36
BandWidth 19.59
MACD Line 0.09
MACD Signal Line 0.18
MACD Histogram -0.0859
Fundamentals Value
Market Cap 150.17 Million
Num Shares 22.5 Million
EPS -1.71
Price-to-Earnings (P/E) Ratio -3.91
Price-to-Sales 0.00
Price-to-Book 2.17
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.24
Resistance 3 (R3) 7.24 7.07 7.14
Resistance 2 (R2) 7.07 6.93 7.06 7.11
Resistance 1 (R1) 6.87 6.84 6.79 6.87 7.08
Pivot Point 6.70 6.70 6.65 6.69 6.70
Support 1 (S1) 6.50 6.56 6.42 6.50 6.28
Support 2 (S2) 6.33 6.47 6.32 6.25
Support 3 (S3) 6.13 6.33 6.22
Support 4 (S4) 6.13